Show simple item record

Effect of progression-free interval (pfi) following penultimate platinum-based regimen on the efficacy of rucaparib maintenance treatment in patients with platinum-sensitive, recurrent ovarian carcinoma: an analysis from the phase 3 study ARIEL3

dc.contributor.authorClamp, Andrew R
dc.contributor.authorOza, AM
dc.contributor.authorLorusso, D
dc.contributor.authorAghajanian, C
dc.contributor.authorOaknin, A
dc.contributor.authorDean, A
dc.contributor.authorColombo, N
dc.contributor.authorWeberpals, JI
dc.contributor.authorScambia, G
dc.contributor.authorLeary, A
dc.contributor.authorHolloway, RW
dc.contributor.authorGancedo, MA
dc.contributor.authorFong, PC
dc.contributor.authorGoh, IC
dc.contributor.authorO'Malley, DM
dc.contributor.authorArmstrong, DK
dc.contributor.authorBanerjee, S
dc.contributor.authorGarcia-Donas, J
dc.contributor.authorSwisher, EM
dc.contributor.authorCameron, T
dc.contributor.authorMaloney, L
dc.contributor.authorGoble, S
dc.contributor.authorColeman, RL
dc.contributor.authorLedermann, JA
dc.date.accessioned2020-06-15T12:57:35Z
dc.date.available2020-06-15T12:57:35Z
dc.date.issued2019en
dc.identifier.citationClamp AR, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, et al. Effect of progression-free interval (PFI) following penultimate platinum-based regimen on the efficacy of rucaparib maintenance treatment in patients with platinum-sensitive, recurrent ovarian carcinoma: an analysis from the phase 3 study ARIEL3. International Journal of Gynecological Cancer. 2019;29:A27-A8.en
dc.identifier.doi10.1136/ijgc-2019-ESGO.28en
dc.identifier.urihttp://hdl.handle.net/10541/622954
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/ 10.1136/ijgc-2019-ESGO.28en
dc.titleEffect of progression-free interval (pfi) following penultimate platinum-based regimen on the efficacy of rucaparib maintenance treatment in patients with platinum-sensitive, recurrent ovarian carcinoma: an analysis from the phase 3 study ARIEL3en
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology, The Christie NHS Foundation Trust and University of Manchester, Manchesteren
dc.identifier.journalInternational Journal of Gynecological Canceren
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record